Qube Research & Technologies LTD Maxcyte, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.94 - $5.38 $46,058 - $62,892	11,690 Added 200.0%	17,535 $73,000
Q4 2023 Feb 13, 2024	SELL	$2.6 - $5.24 $65,171 - $131,345	-25,066 Reduced 81.09%	5,845 $27,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $5.1 $93,351 - $157,646	30,911 New	30,911 $96,000
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $68,637 - $130,200	-19,119 Reduced 47.74%	20,930 $99,000
Q1 2022 May 09, 2022	BUY	$5.26 - $10.84 $210,657 - $434,131	40,049 New	40,049 $280,000

118

65M

600

2.7K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $396M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.